Patent · US Active

Pyrrolidine derivatives as dual NK1/NK3 receptor antagonists

US7893062B2 · kind B2 · utility

2Cited by

2References

15Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Caterina Bissantz · Rixheim, FR
Torsten Hoffmann · Weil am Rhein, DE
Philippe Jablonski · Steinbrunn-le-Haut, FR
Henner Knust · Rheinfelden (Baden), DE
Matthias Nettekoven · Weil am Rhein, DE
Hasane Ratni · Habsheim, FR
Xihan Wu · Shanghai, CN

Key dates

Filing date	Apr 14, 2008
Grant date	Feb 22, 2011
Priority date	—
Expiry date	Aug 15, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/10
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The invention relates to pyrrolidine derivatives of formulawherein

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.